What is the recommended intravenous (IV) dose of hydromorphone for an 8-year-old female weighing 29.3 kilograms (kg)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydromorphone IV Dosing for an 8-Year-Old Female Weighing 29.3 kg

The recommended intravenous (IV) dose of hydromorphone for this 8-year-old female weighing 29.3 kg is 0.015 mg/kg, which equals approximately 0.4-0.5 mg per dose. This dose can be administered every 2-3 hours as needed for pain control 1.

Dosing Calculation and Rationale

The FDA-approved hydromorphone dosing guidelines recommend:

  • For IV administration in opioid-naïve patients: 0.2-1 mg every 2-3 hours as necessary for pain control 1
  • For pediatric patients, this translates to approximately 0.015 mg/kg IV

For this 29.3 kg child:

  • 29.3 kg × 0.015 mg/kg = 0.44 mg per dose
  • Round to 0.4-0.5 mg for practical administration

Administration Considerations

  • Administer IV hydromorphone slowly, over at least 2-3 minutes 1
  • Start at the lower end of the dosing range for pediatric patients
  • Titrate based on the individual patient's response to their initial dose
  • Monitor closely for respiratory depression, which can occur at any time during opioid therapy

Special Considerations for Pediatric Patients

  • Children may require higher mg/kg doses than adults but should still be started at the lowest effective dose
  • Allow sufficient time between doses (2-5 minutes) to assess effect before administering additional medication
  • For patients with hepatic or renal impairment, start with one-fourth to one-half the usual dose 1

Monitoring Requirements

  • Continuous monitoring of vital signs, particularly respiratory rate and oxygen saturation
  • Assess level of sedation frequently
  • Have naloxone readily available for reversal of respiratory depression if needed
  • Monitor for common side effects: nausea, vomiting, pruritus, and constipation

Potential Adverse Effects

  • Respiratory depression is the most serious potential complication
  • Other common side effects include sedation, nausea, vomiting, and pruritus
  • Hydromorphone may cause less pruritus, sedation, and nausea compared to morphine 2

Potency Considerations

  • Hydromorphone is approximately 5 times as potent as morphine orally and 8.5 times as potent as morphine intravenously 2
  • This high potency requires careful dosing, especially in pediatric patients

Remember to use the lowest effective dose for the shortest duration necessary to control pain while minimizing adverse effects. Titrate carefully based on the patient's response and pain assessment.

References

Research

Hydromorphone: pharmacology and clinical applications in cancer patients.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.